|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.88 USD | -0.12% |
|
-2.66% | -11.97% |
| 02-25 | Xylem Approves $1.5 Billion Share Buyback | MT |
| 02-25 | Xylem Inc. announces an Equity Buyback for $1,500 million worth of its shares. | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.2B | 5.52B | 7.36B | 8.56B | 9.04B | |||||
Total Revenues | 5.2B | 5.52B | 7.36B | 8.56B | 9.04B | |||||
Cost of Goods Sold, Total | 3.22B | 3.43B | 4.65B | 5.35B | 5.56B | |||||
Gross Profit | 1.98B | 2.09B | 2.72B | 3.21B | 3.48B | |||||
Selling General & Admin Expenses, Total | 1.19B | 1.24B | 1.63B | 1.86B | 1.93B | |||||
R&D Expenses | 204M | 206M | 232M | 230M | 226M | |||||
Other Operating Expenses, Total | 1.4B | 1.44B | 1.86B | 2.09B | 2.16B | |||||
Operating Income | 582M | 645M | 852M | 1.12B | 1.32B | |||||
Interest Expense, Total | -76M | -50M | -49M | -44M | -29M | |||||
Interest And Investment Income | 7M | 16M | 28M | 28M | 27M | |||||
Net Interest Expenses | -69M | -34M | -21M | -16M | -2M | |||||
Income (Loss) On Equity Invest. | 9M | - | - | -4M | 2M | |||||
Other Non Operating Income (Expenses) | -2M | 1M | 7M | -8M | -4M | |||||
EBT, Excl. Unusual Items | 520M | 612M | 838M | 1.09B | 1.32B | |||||
Restructuring Charges | -10M | -19M | -72M | -55M | -95M | |||||
Merger & Related Restructuring Charges | - | - | -126M | -50M | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | 152M | - | |||||
Gain (Loss) On Sale Of Assets | 2M | 1M | -1M | -46M | -31M | |||||
Asset Writedown | -1M | -14M | -4M | -7M | -8M | |||||
Other Unusual Items | - | -140M | - | - | - | |||||
EBT, Incl. Unusual Items | 511M | 440M | 635M | 1.09B | 1.18B | |||||
Income Tax Expense | 84M | 85M | 26M | 197M | 231M | |||||
Earnings From Continuing Operations | 427M | 355M | 609M | 890M | 950M | |||||
Net Income to Company | 427M | 355M | 609M | 890M | 950M | |||||
Minority Interest | - | - | - | - | 7M | |||||
Net Income - (IS) | 427M | 355M | 609M | 890M | 957M | |||||
Net Income to Common Incl Extra Items | 427M | 355M | 609M | 890M | 957M | |||||
Net Income to Common Excl. Extra Items | 427M | 355M | 609M | 890M | 957M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.37 | 1.97 | 2.81 | 3.67 | 3.93 | |||||
Basic EPS - Continuing Operations | 2.37 | 1.97 | 2.81 | 3.67 | 3.93 | |||||
Basic Weighted Average Shares Outstanding | 180M | 180M | 217M | 243M | 243M | |||||
Net EPS - Diluted | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 | |||||
Diluted EPS - Continuing Operations | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 | |||||
Diluted Weighted Average Shares Outstanding | 182M | 181M | 218M | 244M | 244M | |||||
Normalized Basic EPS | 1.8 | 2.12 | 2.41 | 2.82 | 3.41 | |||||
Normalized Diluted EPS | 1.79 | 2.11 | 2.4 | 2.81 | 3.4 | |||||
Dividend Per Share | 1.12 | 1.2 | 1.32 | 1.44 | 1.6 | |||||
Payout Ratio | 47.54 | 61.13 | 49.1 | 39.33 | 40.86 | |||||
Supplemental Items | ||||||||||
EBITDA | 827M | 881M | 1.29B | 1.68B | 1.89B | |||||
EBITA | 709M | 770M | 1.1B | 1.42B | 1.63B | |||||
EBIT | 582M | 645M | 852M | 1.12B | 1.32B | |||||
EBITDAR | 936M | 987M | 1.41B | 1.82B | 2.04B | |||||
Total Revenues (As Reported) | - | - | 7.36B | 8.56B | 9.04B | |||||
Effective Tax Rate - (Ratio) | 16.44 | 19.32 | 4.09 | 18.12 | 19.56 | |||||
Current Domestic Taxes | 21M | 93M | 19M | 143M | 158M | |||||
Current Foreign Taxes | 53M | 56M | 86M | 90M | 108M | |||||
Total Current Taxes | 74M | 149M | 105M | 233M | 266M | |||||
Deferred Domestic Taxes | -2M | -55M | -57M | -49M | -37M | |||||
Deferred Foreign Taxes | 12M | -9M | -22M | 13M | 2M | |||||
Total Deferred Taxes | 10M | -64M | -79M | -36M | -35M | |||||
Normalized Net Income | 325M | 382M | 524M | 683M | 829M | |||||
Interest on Long-Term Debt | - | - | 2M | 4M | 6M | |||||
Non-Cash Pension Expense | 14M | 150M | 2M | 3M | 5M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 204M | 206M | 235M | 231M | 226M | |||||
Net Rental Expense, Total | 109M | 106M | 123M | 139M | 144M | |||||
Imputed Operating Lease Interest Expense | 21.67M | 17.13M | 19.58M | 18.93M | 13.59M | |||||
Imputed Operating Lease Depreciation | 87.33M | 88.87M | 103M | 120M | 130M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | 53M | |||||
Stock-Based Comp., Other (Total) | 33M | 37M | 60M | 56M | - | |||||
Total Stock-Based Compensation | 33M | 37M | 60M | 56M | 53M |
- Stock Market
- Equities
- XYL Stock
- Financials Xylem Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















